foxo4-dri senolytic peptide human trial 2024 2025 regulates endothelial cell senescence via the P53 signaling pathway Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram Cellular Senescence in Health, Disease, and Lens Aging
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3


